Table: SymBio Pharmaceuticals - 6-MTH group results

SymBio Pharmaceuticals

31/07/2025 07:35

Jul 31 (Reuters)- 
             SymBio Pharmaceuticals Limited 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to  
                Jun 30, 2025        Jun 30, 2024      Dec 31, 2025  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            646 mln              1.28              1.40      
                 (-49.7 pct)         (-59.6 pct)       (-42.9 pct)  
  Operating       loss 2.15           loss 1.72         loss 4.26   
  Recurring       loss 2.34           loss 1.48         loss 4.47   
  Net             loss 2.37           loss 1.54         loss 4.59   
  EPS          loss 49.35 yen      loss 34.75 yen    loss 95.95 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - SymBio Pharmaceuticals Limited. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T